MiMedx Group, Inc. Sustainability Profile
MiMedx Group, Inc., a leading biotechnology firm headquartered in the United States, specialises in regenerative medicine and advanced wound care. Founded in 2008, the company has made significant strides in the industry, particularly in the development of placental tissue-based products that promote healing and tissue regeneration. With a strong presence across North America, MiMedx focuses on innovative solutions for chronic wounds and surgical applications. Its core offerings, including allografts and amniotic tissue products, are distinguished by their unique properties that enhance patient recovery. Recognised for its commitment to quality and efficacy, MiMedx has established a notable market position, contributing to advancements in healthcare and improving patient outcomes.
DitchCarbon Score
How does MiMedx Group, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MiMedx Group, Inc.'s score of 31 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MiMedx Group, Inc.'s reported carbon emissions
MiMedx Group, Inc., headquartered in the US, has set ambitious climate commitments despite not having specific carbon emissions data available for recent years. The company aims to reduce its Scope 1 emissions by 25% by 2030, with a target start year of 2024. Additionally, MiMedx has committed to achieving net zero Scope 1 emissions by 2050. In terms of Scope 2 emissions, MiMedx also targets a 25% reduction by 2030, starting in 2024, and aims for net zero Scope 2 emissions by 2050. These initiatives reflect the company's proactive approach to addressing climate change and reducing its carbon footprint in line with industry standards.
How Carbon Intensive is MiMedx Group, Inc.'s Industry?
How Carbon Intensive is MiMedx Group, Inc.'s Location?
MiMedx Group, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MiMedx Group, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
